Recent Posts

Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical Trial

Katie Lew · August 29, 2024

August 29, 2024

Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical Trial

Ground-breaking investigational product from Melodi Health is designed to reduce post-surgical infections

August 27, 2024

NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease Treatment

EXCELSIOR, Minn. – Aug. 27, 2024 – PRLog — NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced

August 27, 2024

Biocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter Coating

Horsham, PA, [August 27, 2024] – Biocoat Incorporated, a leader in the

ECRI Issues Evidence Bar “Favorable” Rating for Sonex Health’s UltraGuideCTR

Tyler Mason

June 7, 2024

ECRI Issues Evidence Bar “Favorable” Rating for Sonex Health’s UltraGuideCTR

Emerging Therapy Solutions Appoints Ashley Hume to President to Drive Solutions Growth in Cell and Gene Therapy Market

Tyler Mason

June 6, 2024

Emerging Therapy Solutions Appoints Ashley Hume to President to Drive Solutions Growth in Cell and Gene Therapy Market

AVS Receives IDE Approval from FDA for Pivotal Intravascular Lithotripsy Study

Tyler Mason

June 6, 2024

AVS Receives IDE Approval from FDA for Pivotal Intravascular Lithotripsy Study

Switchback Medical Expands Operations Space

Tyler Mason

June 5, 2024

Switchback Medical Expands Operations Space

Learn more about [your subject]. Start Now!

Click the button to get started!

Success message!

Warning message!

Error message!